Chang Wei Hung, Su Chien-Chou, Chen Kao Chin, Hsiao Yin Ying, Chen Po See, Yang Yen Kuang
Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Department of Psychiatry, National Cheng Kung University Hospital, Dou-Liou Branch, Yunlin, Taiwan.
Clin Psychopharmacol Neurosci. 2023 Aug 31;21(3):478-487. doi: 10.9758/cpn.22.991.
Previous studies have shown that certain severe mental illnesses (SMIs) increase the risk of dementia, but those that increase the risk to a greater degree in comparison with other SMIs are unknown. Furthermore, physical illnesses may alter the risk of developing dementia, but these cannot be well-controlled.
Using the Taiwan National Health Insurance Research Database, patients with schizophrenia, bipolar disorder and major depressive disorder (MDD) were recruited. We also recruited normal healthy subjects as the control group. All subjects were aged over 60 years, and the duration of follow-up was from 2008 to 2015. Multiple confounders were adjusted, including physical illnesses and other variables. Use of medications, especially benzodiazepines, was analyzed in a sensitivity analysis.
36,029 subjects (MDD: 23,371, bipolar disorder: 4,883, schizophrenia: 7,775) and 108,084 control subjects were recruited after matching according to age and sex. The results showed that bipolar disorder had the highest hazard ratio (HR) (HR: 2.14, 95% confidence interval [CI]: 1.99-2.30), followed by schizophrenia (HR: 2.06, 95% CI: 1.93-2.19) and MDD (HR: 1.60, 95% CI: 1.51-1.69). The results remained robust after adjusting for covariates, and sensitivity analysis showed similar results. Anxiolytics use did not increase the risk of dementia in any of the three groups of SMI patients.
SMIs increase the risk of dementia, and among them, bipolar disorder confers the greatest risk of developing dementia. Anxiolytics may not increase the risk of developing dementia in patients with an SMI, but still need to be used with caution in clinical practices.
既往研究表明,某些严重精神疾病(SMIs)会增加患痴呆症的风险,但与其他SMIs相比,哪些疾病会更大程度地增加这种风险尚不清楚。此外,躯体疾病可能会改变患痴呆症的风险,但这些因素无法得到很好的控制。
利用台湾全民健康保险研究数据库,招募了精神分裂症、双相情感障碍和重度抑郁症(MDD)患者。我们还招募了正常健康受试者作为对照组。所有受试者年龄均超过60岁,随访时间为2008年至2015年。对多个混杂因素进行了调整,包括躯体疾病和其他变量。在敏感性分析中分析了药物使用情况,尤其是苯二氮䓬类药物。
根据年龄和性别匹配后,招募了36029名受试者(MDD:23371名,双相情感障碍:4883名,精神分裂症:7775名)和108084名对照受试者。结果显示,双相情感障碍的风险比(HR)最高(HR:2.14,95%置信区间[CI]:1.99 - 2.30),其次是精神分裂症(HR:2.06,95% CI:1.93 - 2.19)和MDD(HR:1.60,95% CI:1.51 - 1.69)。在调整协变量后,结果仍然稳健,敏感性分析显示了相似的结果。在三组SMI患者中,使用抗焦虑药均未增加患痴呆症的风险。
SMIs会增加患痴呆症的风险,其中双相情感障碍患痴呆症的风险最大。抗焦虑药可能不会增加SMI患者患痴呆症的风险,但在临床实践中仍需谨慎使用。